Analystreport

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

Kiniksa Pharmaceuticals, Ltd. - Class A  (KNSA) 
Last kiniksa pharmaceuticals, ltd. - class a earnings: 8/12 04:02 pm Check Earnings Report